şizofrenik bozuklukta cinsel işlev bozuklukları - Çukurova Üniversitesi

130. Xiaoduo F, David CH, Elaine C, Leah BNB, Oliver F, A Eden E, Corinne C, Donald CG. Sexual
functioning, psychopathology and quality of life in patients with schizophrenia. Schizophrenia
Research 2007; 94: 119-127.
131. Kelly DL, Conley RR. Sexuality and schizophrenia: a review. Schizophr. Bull. 2004; 30, 767-769.
132. Macdonald S, Halliday J, Mac ET, Sharkey V, Farrington S, Wall S, McCreadie RG. Nithsdale
Schizophrenia Surveys 24: sexual dysfunctioon. Case-control study. Br. J. Psychiatry. 2003; 182, 50-
56.
133. Smith SM, O’Keane V, Murray R. Sexual dysfunction in patients taking conventional
antipsychotic medication. Br. J. Psychiatry. 2002; 181, 49-55.
134. Schiavi RC, Stimmel BB, Mandeli J, Schreiner-Engel P and Ghizzani A. Diabetes, psychological
function and male sexuality. Journal of Psychosomatic Research, 1995; 39:305-314.
135. Cohn JB, Brust J, DiSerio F, and Singer J. Effect of bromocriptine mesylate on induced
hyperprolactinemia in stabilized psychiatric outpatients undergoing neuroleptic treatment.
Pharmacopsychiatry. 1985; 13:173-179.
136. Pollack MH and Rosenbaum JF. Management of antidepressant-induced side effects: A partical
guide for the clinician. Joutrnal of Clinical Psychiatry, 1987; 48:3-8.
137. Sovner R. Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine.
[Letter]. Journal of Clinical Psychiatry. 1984; 4:169.
138. Balogh S, Hendricks SE and Kang J. Treatment of fluoxetine-induced anorgasmia with
amantadine. [Letter]. Journal of Clinical Psychiatry. 1992; 53:212-213.
139. Lare SB and Labbate LA. Sildenafil and erectile dysfunction. [Letter]. American Journal of
Psychiatry. 2000; 157:2055-2056.
140. Gopalakrishnan R, Jacob KS, Kuruvilla A, et al. Sildenafil in the treatment of antipsychoticinduced
erectile dysfunction: a randomized, double blind, placebo-controlled, flexible-dose, two-way
crossover tral. Am J Psychiatry 2006; 163:494-499.
141. Sabuncu T, Arikan E, Tasan E and Hatemi H. Comparison of the effects of cabergoline and
bromocriptine on prolactin levels in hyperprolactinemic patients. İnternal Medicine, 2001; 40:857-
861.
142. Yamada K, Kanba S, Yagi G and Asai M. Herbal medicine (Shakuyaku-kanzo-to) in the treatment
of risperidone-induced amenorrhea. [Letter]. Journal of Clinical Psychopharmacology. 1999;
19:380-381.
143. Yamada K, Kanba S, Yagi G and Asai M. Effectiveness of herbal medicine (shakuyaku-kanzo-to)
for neuroleptic-induced hyperprolactinemia. [Letter]. Journal of Clinical Psychopharmacology.
1997; 17:234-235.
144. Munarriz R, Talakoub L, Flaherty E, Gioia M Hoag L, Kim NN, Traish A, Goldstein I, Guay A
and Spark R. Androgen replecement therapy with dehydroepiandesterone for androgen
insufficiency and female sexual dysfunction: Androgen and questionnaire results. Journal of Sex and
Marital Therapy. 2002; 28:165-173.
60